Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
肠道菌群与胰腺炎及胰腺癌关系的研究进展
( views:137, downloads:113 )
Author:
No author available
Journal Title:
Chinese Journal of Pancreatology
Issue:
3
DOI:
10.3760/cma.j.cn115667-20200521-00077
Key Word:
肠道菌群;急性胰腺炎;慢性胰腺炎;胰腺癌
Abstract: 随着肠道菌群相关研究的深入,目前发现肠道菌群可参与调节胰腺生理功能,并且与胰腺炎及胰腺癌的发病存在相关性。本文围绕肠道菌群与急性胰腺炎、慢性胰腺炎和胰腺癌关系的研究进展做一综述。
Reference
[1]刘江,吉顺荣,张波,等.
血浆D-二聚体水平对胰腺癌分期及化疗效果的预测价值
[J].2018,(4).
[2]孙伟,任贺,金鹏,等.
凝血参数异常对胰腺癌诊治的临床意义
[J].2013,(5).
[3]David Ansari,Daniel Ansari,Roland Andersson,etc.
Pancreatic cancer and thromboembolic disease, 150 years after Trousseau
[J].2015,(5).
[4]周雨,林叶,简志祥.
治疗前血小板水平与胰腺癌预后相关性的Meta分析
[J].2017,(6).
[5]王文闻,肖燕,王琦.
血浆D-二聚体在胰腺癌患者中的临床意义
[J].2020,(3).
[6]王婧,赵磊,车娟娟,等.
D-Dimer与胰腺癌Ⅳ期患者生存期及预后的相关性研究
[J].2016,(5).
[7]Unruh Dusten,Horbinski Craig.
Beyond thrombosis: the impact of tissue factor signaling in cancer
[J].2020,13(1).
[8]Zhang, Ke,Gao, Hui-Feng,Mo, Miao,etc.
A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer
[J].2019,19(2).
[9]Adam, Durczynski,Aleksander, Skulimowski,Piotr, Hogendorf,etc.
The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer.
[J].2017,15(1).
[10]曹军丽,王欣,郑磊,等.
D-二聚体、糖类抗原199和胰岛素样生长因子结合蛋白2对可切除胰腺癌患者术后监测和生存期预测的价值
[J].2020,(7).
[11]Rickles FR.
Mechanisms of cancer-induced thrombosis in cancer.
[J].2006,35(1).
[12]Qi, Qi,Chen, Hao,Wang, Peng,etc.
Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer
[J].2015,44(6).
[13]Alyce J,Mayfosh,Nikola,Baschuk,Mark D,Hulett.
Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.
[J].2019,9.
[14]Elaskalani, Omar,Berndt, Michael C.,Falasca, Marco,etc.
Targeting Platelets for the Treatment of Cancer
[J].2017,9(7).
[15]Peng, Liu,Yuan, Zhu,Luying, Liu.
Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma.
[J].2015,8.
[16]A B, Glassman,E, Jones.
Thrombosis and coagulation abnormalities associated with cancer.
[J].1900,24(1).
[17]Risch, Harvey A.,Lu, Lingeng,Streicher, Samantha A.,etc.
Aspirin Use and Reduced Risk of Pancreatic Cancer
[J].2017,26(1).
[18]Pegah, Mir Seyed Nazari,Julia, Riedl,Ingrid, Pabinger,etc.
The role of podoplanin in cancer-associated thrombosis.
[J].2018,1641(Spec ).
[19]Rui, Ji,Qian, Ren,Suyang, Bai,etc.
Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis.
[J].2018,97(25).
[20]Hong,Dai,Hongxing,Zhou,Yingxin,Sun,etc.
D-dimer as a potential clinical marker for predicting metastasis and progression in cancer.
[J].2018,9(5).
[21].
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes
[J].2020,158(5).
[22]Adam Durczynski,Anna Kumor,Piotr Hogendorf,etc.
Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer
[J].2014,(36).
[23]Chung, Kwang Hyun,Lee, Jong-Chan,Lee, Jongchan,etc.
Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
[J].2020,20(7).
[24]Kimberly M. Brown,Christinnah Domin,Gerard V. Aranha,etc.
Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas
[J].2005,189(3).
[25]Wu, Wujun,Zhao, Lin,Yu, Yongtian,etc.
Heparanase expression in blood is sensitive to monitor response to anticancer treatment in pancreatic cancer, a pilot study
[J].2018,18(1).
[26]Kazuyoshi Hirayama,Hiroshi Kono,Yuuki Nakata,etc.
Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer
[J].2018,48(1).
[27]Ebrahimi, Safieh,Rahmani, Farzad,Behnam-Rassouli, Reihane,etc.
Proinflammatory signaling functions of thrombin in cancer
[J].2017,232(9).
[28]Wang,H.,Gao,J.,Bai,M.,etc.
The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer
[J].2014,25(5).
[29]Yukinari, Kato,Mika Kato, Kaneko.
A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.
[J].2014,4.
[30]Cao Junli,Fu Zhanzhao,Gao Liming,etc.
Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma
[J].2017,15(1).
[31]Mezouar, Soraya,Frere, Corinne,Darbousset, Roxane,etc.
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
[J].2016,139.
[32]Qingqu, Guo,Bo, Zhang,Xin, Dong,etc.
Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor.
[J].2009,38(3).
[33]Ryoichi, Miyamoto,Tatsuya, Oda,Shinji, Hashimoto,etc.
Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer.
[J].2017,46(1).
[34]Stender, Mogens T.,Larsen, Anders C.,Sall, Mogens,etc.
D-Dimer predicts prognosis and non-resectability in patients with pancreatic cancer: a prospective cohort study
[J].2016,27(5).
[35]Caine, Graham J.,Stonelake, Paul S.,Lip, Gregory Y. H.,etc.
The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate.
[J].2002,4(6).
[36]Campello, Elena,Ilich, Anton,Simioni, Paolo,etc.
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
[J].2019,121(5).
[37]Gy?rgy Blaskó,Dorottya Valtinyi,Larisza László,etc.
D-dimer as a potential prognostic marker.
[J].2012,18(3).
[38]Johannes Thaler,Cihan Ay,Ingrid Pabinger.
Biomarkers for prediction of venous thromboembolism in cancer.
[J].2013,122(12).
[39]Hisada Y.,Ay C.,Auriemma A. C.,etc.
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size
[J].2017,15(11).
[40]Mousa SA.
Role of current and emerging antithrombotics in thrombosis and cancer.
[J].2006,42(5).
[41]Katherine E,Poruk.
Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
[J].2010,19.
[42]Sun, Wei,Hao, Ji-Hui,Ma, Wei-Dong,etc.
Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism
[J].2015,38(6).
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn